Published in Surgery Litigation and Law Weekly, March 30th, 2007
This trend article about Medical University of South Carolina, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Fresh data on head and neck cancer are presented in the report "Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users." In this recent study, researchers in the United States conducted a study "To determine whether ongoing use of a cyclooxygenase (COX) inhibitor is associated with a reduction in mortality and disease recurrence after head and neck cancer treatment. Retrospective...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly